Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6108]

World leaders gathering at Davos face calls for bold action to turn the tide on cancer

World leaders gathering at Davos face calls for bold action to turn the tide on cancer

Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list

Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list

Disappointment over NHS England's bowel cancer drug decision

Disappointment over NHS England's bowel cancer drug decision

CHMP opinion recommends bortezomib for use in mantle cell lymphoma

CHMP opinion recommends bortezomib for use in mantle cell lymphoma

European call for action on cancer immunotherapies

European call for action on cancer immunotherapies

Olaparib approved in the EU as treatment for advanced BCRA-mutated ovarian cancer

Olaparib approved in the EU as treatment for advanced BCRA-mutated ovarian cancer

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer patients

ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer...

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: Anticoagulation after incidental pulmonary embolism may reduce risk of clot recurrence in cancer patients

ASH 2014: First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia

ASH 2014: First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

ASH 2014: Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia

More from ecancer